Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Vet Dermatol ; 33(3): 237-e65, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35199400

ABSTRACT

Pemphigus vulgaris is a rare immune-mediated skin disorder of the dog, usually treated with immunosuppressive medications such as oral glucocorticoids, azathioprine or ciclosporin. Herein we report the successful treatment of pemphigus vulgaris in a dog, using oclacitinib and a topical product containing fucidic acid (0.5 % w/w) and betamethasone valerate.


Le pemphigus vulgaire est une affection cutanée rare à médiation immune chez le chien, généralement traitée avec des médicaments immunosuppresseurs tels que les glucocorticoïdes oraux, l'azathioprine ou la ciclosporine. Nous décrivons ici le traitement efficace du pemphigus vulgaire chez un chien, à l'aide d'oclacitinib et d'un produit topique contenant de l'acide fucidique (0,5 % p/p) et du valérate de bétaméthasone.


O pênfigo vulgar é uma dermatopatia imunomediada dos cães, que é usualmente tratada com medicações imunossupressoras como corticoides por via oral, azatioprina ou ciclosporina. No presente estudo, relatamos o tratamento de bem sucedido de penfigp vulgaris em um cão, utilizando o oclacitinib e um produto tópico contendo ácido fusídico (0,5 % w/w) e valerato de betametasona.


El pénfigo vulgar es un trastorno inmunomediado cutáneo poco frecuente en perros, generalmente tratado con medicamentos inmunosupresores como glucocorticoides orales, azatioprina o ciclosporina. En este artículo describimos el tratamiento exitoso de pénfigo vulgar en un perro utilizando oclacitinib y un producto tópico que contiene ácido fucídico (0,5 % p/p) y valerato de betametasona.


Subject(s)
Dog Diseases , Pemphigus , Animals , Azathioprine/therapeutic use , Dog Diseases/drug therapy , Dogs , Immunosuppressive Agents/therapeutic use , Pemphigus/drug therapy , Pemphigus/veterinary , Pyrimidines/therapeutic use , Sulfonamides/therapeutic use
2.
Vet Dermatol ; 32(3): 256-e69, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33720452

ABSTRACT

BACKGROUND: Dogs with cutaneous diseases often receive supplementation with omega-3 (n-3) and omega-6 (n-6) essential fatty acids (FA), either through their diet or the use of an oral supplement. Labelling on these products is not always clear, especially regarding the total and relative amounts of FA. OBJECTIVES: To provide clinicians with a breakdown of the FA content of selected veterinary diets, supplements and fish oil capsules so that the daily dose of supplementation can be calculated more easily. Repeated measurements of FA content over time demonstrate whether FA content changes temporally. METHODS AND MATERIALS: Eight veterinary diets, four veterinary oral FA supplements and four fish oil supplements were analysed for FA content by gas chromatography at days 0, 28 and 56. RESULTS: The n-6:n-3 ratio varied among the supplement types with the food samples having higher ratios than the liquid supplements and fish oil capsules. The composition of n-3 FA differed between products with some having higher concentrations of the less active n-3 FA alpha-linolenic acid than eicosapentaenoic acid and docosahexaenoic acid. No decreases in FA content over time were detected. CONCLUSIONS AND CLINICAL RELEVANCE: The results of this study provide the reader with a means to calculate the FA concentrations that their patient is receiving for each product tested, as well as allowing them to compare products for their differences in n-6:n-3 ratios and relative amounts of individual FA molecules. The FA concentrations did not change significantly over 56 days.


Subject(s)
Fatty Acids , Fish Oils , Animals , Capsules , Diet , Dietary Supplements , Dogs
3.
Vet Rec ; 187(5): 190, 2020 Sep 05.
Article in English | MEDLINE | ID: mdl-31690643

ABSTRACT

BACKGROUND: The aim of the study was to discover the extent of use of essential fatty acids (EFAs) in veterinary practice, conditions used in, preparation of EFA supplement used and rationale for their use and to investigate the awareness of the oxidation of some commercial fish oil supplement preparations. METHODS: A web-based questionnaire was distributed via email to a dermatology list server and posted to veterinary Facebook groups with questions relating to the use of EFAs, supplement choice, conditions used in, the level of importance of various factors regarding their use and awareness of their oxidation. RESULTS: There were 309 responses from 32 countries. EFA supplements were used by 92.2 per cent of respondents. The most commonly used preparation of EFA supplementation was veterinary oral supplements (75.1 per cent), followed by veterinary diets (14.4 per cent), shop bought fish oil supplements (7.7 per cent), enhancing the diet with oily fish (2.5 per cent) and finally using a commercial pet food (0.3 per cent). Only 46.3 per cent of respondents who used them were aware of the oxidation of EFAs. Veterinary oral supplements were perceived to be the best preserved, followed by veterinary diets and lastly commercial fish oil supplements. CONCLUSION: A large number of respondents advised the use of EFAs for veterinary dermatological conditions but less than 50 per cent were aware of the potential for EFAs to oxidise.


Subject(s)
Dermatology , Fatty Acids, Essential/therapeutic use , Skin Diseases/veterinary , Veterinary Medicine , Animals , Humans , Skin Diseases/drug therapy , Surveys and Questionnaires
4.
Animals (Basel) ; 9(1)2018 Dec 21.
Article in English | MEDLINE | ID: mdl-30577619

ABSTRACT

This article, written by veterinarians whose caseloads include brachycephalic dogs, argues that there is now widespread evidence documenting a link between extreme brachycephalic phenotypes and chronic disease, which compromises canine welfare. This paper is divided into nine sections exploring the breadth of the impact of brachycephaly on the incidence of disease, as indicated by pet insurance claims data from an Australian pet insurance provider, the stabilization of respiratory distress associated with brachycephalic obstructive airway syndrome (BOAS), challenges associated with sedation and the anaesthesia of patients with BOAS; effects of brachycephaly on the brain and associated neurological conditions, dermatological conditions associated with brachycephalic breeds, and other conditions, including ophthalmic and orthopedic conditions, and behavioural consequences of brachycephaly. In the light of this information, we discuss the ethical challenges that are associated with brachycephalic breeds, and the role of the veterinarian. In summary, dogs with BOAS do not enjoy freedom from discomfort, nor freedom from pain, injury, and disease, and they do not enjoy the freedom to express normal behaviour. According to both deontological and utilitarian ethical frameworks, the breeding of dogs with BOAS cannot be justified, and further, cannot be recommended, and indeed, should be discouraged by veterinarians.

5.
Proteome Sci ; 10(1): 33, 2012 May 18.
Article in English | MEDLINE | ID: mdl-22607704

ABSTRACT

BACKGROUND: Signal peptide peptidase (SPP), a member of the presenilin-like intra-membrane cleaving aspartyl protease family, migrates on Blue Native (BN) gels as 100 kDa, 200 kDa and 450 kDa species. SPP has recently been implicated in other non-proteolytic functions such as retro-translocation of MHC Class I molecules and binding of misfolded proteins in the endoplasmic reticulum (ER). These high molecular weight SPP complexes might contain additional proteins that regulate the proteolytic activity of SPP or support its non-catalytic functions. RESULTS: In this study, an unbiased iTRAQ-labeling mass spectrometry approach was used to identify SPP-interacting proteins. We found that vigilin, a ubiquitous multi-KH domain containing cytoplasmic protein involved in RNA binding and protein translation control, selectively enriched with SPP. Vigilin interacted with SPP and both proteins co-localized in restricted intracellular domains near the ER, biochemically co-fractionated and were part of the same 450 kDa complex on BN gels. However, vigilin does not alter the protease activity of SPP, suggesting that the SPP-vigilin interaction might be involved in the non-proteolytic functions of SPP. CONCLUSIONS: We have identified and validated vigilin as a novel interacting partner of SPP that could play an important role in the non-proteolytic functions of SPP. This data adds further weight to the idea that intramembrane-cleaving aspartyl proteases, such as presenilin and SPPs, could have other functions besides the proteolysis of short membrane stubs.

6.
FEBS Lett ; 583(4): 739-42, 2009 Feb 18.
Article in English | MEDLINE | ID: mdl-19185576

ABSTRACT

Voltage dependent anion channel (VDAC) is a vital ion channel in mitochondrial outer membranes and its structure was recently shown to be a 19 stranded beta-barrel. However the orientation of VDAC in the membrane remains unclear. We probe here the topology and membrane orientation of yeast Saccharomyces cerevisiae in vivo. Five FLAG-epitopes were independently inserted into scVDAC1 and their surface exposure in intact and disrupted mitochondria detected by immunoprecipitation. Functionality was confirmed by measurements of respiration. Two epitopes suggest that VDAC (scVDAC) has its C-terminus exposed to the cytoplasm whilst two others are more equivocal and, when combined with published data, suggest a dynamic behavior.


Subject(s)
Ion Channels/genetics , Membrane Transport Proteins/genetics , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae/genetics , Voltage-Dependent Anion Channels/genetics , Amino Acid Sequence , Cloning, Molecular , Cytoplasm/genetics , Cytoplasm/metabolism , Membrane Proteins/genetics , Mitochondria/genetics , Mitochondria/metabolism , Mitochondrial Membranes/chemistry , Mitochondrial Membranes/metabolism , Models, Molecular , Molecular Sequence Data , Mutagenesis, Site-Directed , Protein Conformation , Saccharomyces cerevisiae/metabolism , Saccharomyces cerevisiae Proteins/metabolism , Sequence Homology, Amino Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...